DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Allison M. Kirk(St. Jude Children's Research Hospital), Paul G. Thomas(St. Jude Children's Research Hospital)
Cited by 13
Related Papers
Influenza virus-related critical illness: pathophysiology and epidemiology
|Critical Care|2019|509
New advances in CMV and immunosenescence
|Experimental Gerontology|2014|149